Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €7.20 EUR
Change Today +0.10 / 1.41%
Volume 6.5K
ALDEI On Other Exchanges
Symbol
Exchange
EN Paris
OTC US
Frankfurt
As of 7:24 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

deinove (ALDEI) Snapshot

Open
€7.10
Previous Close
€7.10
Day High
€7.20
Day Low
€7.10
52 Week High
09/3/14 - €11.82
52 Week Low
01/29/15 - €5.90
Market Cap
42.5M
Average Volume 10 Days
15.4K
EPS TTM
€-1.18
Shares Outstanding
5.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DEINOVE (ALDEI)

Related News

No related news articles were found.

deinove (ALDEI) Related Businessweek News

No Related Businessweek News Found

deinove (ALDEI) Details

DEINOVE SA, a green technologies company, engages in the development and commercial exploitation of bioprocesses for the production of biofuels and bio sourced chemical compounds based on the use of bacteria. It focuses on developing processes used to create industrially-relevant compounds from non-food biomass. The company was founded in 2006 and is headquartered in Grabels, France.

48 Employees
Last Reported Date: 03/31/15
Founded in 2006

deinove (ALDEI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

deinove (ALDEI) Key Developments

Deinove SA Unveils Bio-Based Muconic Acid Production Program

Deinove SA announced that it has completed conclusive proof of concept for the production of muconic acid by a Deinococcus bacterium and has decided to launch a new R&D platform in this field. Using their proprietary metabolic engineering tools, DEINOVE R&D has successfully designed a Deinococcus bacterium capable of producing renewable muconic acid, a particularly sought-after chemical intermediate, from a variety of feedstocks. This project's development, alongside the Deinol and Deinochem programs, is based on thorough analyses of the technical and economic opportunities and competitive landscape: At the technical level, the physiology of Deinococcus is well-suited for the production of this molecule, providing a critical competitive advantage compared with other alternatives. Indeed, the aerobic muconic acid production is close to the normal physiology of these bacteria and their metabolic flow is more favorable to this fermentation than other reference microorganisms. At the commercial level, muconic acid is a versatile chemical intermediate whose derivatives - caprolactam, terephthalic acid (a precursor to PET) and adipic acid - are widely used in the plastics industry (notably for automotive and packaging applications), the production of synthetic fibers for textiles or industry (mainly nylon) and food (acidifying agent). The combined annual market value of these products is estimated to be worth several tens of billions of dollars. Currently, these molecules rely on non-sustainable, price-fluctuating benzene and cyclohexane. There is a strong demand for the production of identical bio-based alternatives such as in green bottling, the nylon industry and food applications. The existence of a significant market, a real demand and a favorable production economic equation have led Deinove to develop a program for bio-based muconic acid production.

Deinove SA Announces Strategic Partnership with POS Bio-Sciences for the Development of Carotenoid Production Process

DEINOVE announced that it has struck a strategic partnership with the POS Bio-Sciences for the development of its carotenoid production process including the extraction and purification of these high added-value compounds. As part of its DEINOCHEM bio-based chemicals project, DEINOVE has worked for several years to leverage the natural propensity of Deinococcus to produce carotenoids. The work on the characterization of its 6,000-strain bank resulted in a palette of various carotenoids, some even totally unique, like Deinoxanthin, that can be enhanced by DEINOVE’s biotechnological tools. The objective of the company is now to exploit this opportunity commercially. DEINOVE has decided to join forces with POS Bio-Sciences to make progress in structuring its carotenoids portfolio. POS Bio-Sciences is a recognized leader in the extraction of high-value compounds, including carotenoids, based on proven processes.

Deinove SA Presents at Second French Life Science Days Conference, Jun-17-2015

Deinove SA Presents at Second French Life Science Days Conference, Jun-17-2015 . Venue: W Hotel, 541 Lexington Avenue, New York, NY 10022, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALDEI:FP €7.20 EUR +0.10

ALDEI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALDEI.
View Industry Companies
 

Industry Analysis

ALDEI

Industry Average

Valuation ALDEI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 216.2x
Price/Book 7.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 220.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEINOVE, please visit www.deinove.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.